跳至主要内容
临床试验/NCT04807868
NCT04807868招募中不适用

AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)

AdventHealth Translational Research Institute1 个研究点 分布在 1 个国家目标入组 1,250 人开始时间: 2021年4月22日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
1,250
试验地点
1
主要终点
Creation of a Biobank of Liver Tissue Paired with a Registry of Histological and Clinical Metadata

研究概览

简要总结

The purpose of this study is to create a resource that will advance research that is focused on discovery of novel therapies, risk stratification, and aggressive interventions for those at highest risk for non-alcoholic fatty liver disease (NAFLD). To achieve this, we will generate a biobank of liver tissue collected during standard of care liver biopsies. Paired blood/urine samples, FibroScan and relevant data will also be collected.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Creation of a Biobank of Liver Tissue Paired with a Registry of Histological and Clinical Metadata

时间窗: Baseline

次要结局

  • Creation of a Biobank of Blood and Urine Samples Paired with a Registry of Associated Histological and Clinical Metadata(Baseline with annual follow up for up to 5 years)
  • Change in Liver Fat and Fibrosis Over Time ad Measured with FibroScan Controlled Attenuation Parameter and Vibration Controlled Transient Elastography, respectively(Baseline with annual follow up for up to 5 years)

研究者

发起方
AdventHealth Translational Research Institute
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验